arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

GRI Bio, Inc.

GRI

$1.61 ▲ +0.06 (+3.87%) at close

27 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

GRI Bio, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.9M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -12.7% ↗

FCF / Share $-0.80 ↗

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-2.00M

↑ +34.4% —

FCF / Share Free cash flow per share

$-0.80

↑ +73.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	97.5% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	99.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	92.1% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	88.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	98.4% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	94.3% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	98.9% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	98.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	98.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	98.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	13.5% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	80.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	53.5% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	54.5% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	75.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	41.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	-39.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	21.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	-36.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	34.4% Excellent ↑ Excellent Improving Year-over-year change in net income	34.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-36.5% Weak ↑ Weak Improving Year-over-year change in net income	-61.4% Weak ↓ Weak Declining Year-over-year change in net income	-61.4% Weak ↓ Weak Declining Year-over-year change in net income	-61.4% Weak ↓ Weak Declining Year-over-year change in net income	2.8% Caution ↓ Caution Declining Year-over-year change in net income	12.2% Fair ↓ Fair Declining Year-over-year change in net income	12.2% Fair ↓ Fair Declining Year-over-year change in net income	21.2% Good ↑ Good Improving Year-over-year change in net income	11.7% Fair ↓ Fair Declining Year-over-year change in net income	18.4% Good → Good Stable Year-over-year change in net income	18.4% Good ↑ Good Improving Year-over-year change in net income	9.1% Fair → Fair Stable Year-over-year change in net income	26.7% Excellent ↑ Excellent Improving Year-over-year change in net income	0.1% Caution ↑ Caution Improving Year-over-year change in net income	0.1% Caution ↑ Caution Improving Year-over-year change in net income	0.1% Caution ↑ Caution Improving Year-over-year change in net income	-110.8% Weak ↑ Weak Improving Year-over-year change in net income	-127.2% Weak → Weak Stable Year-over-year change in net income	-127.2% Weak Weak Year-over-year change in net income	-127.4% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	96.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.84x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.57x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.17x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	2.77x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-12.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-35.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-133.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-200.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-46.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-618.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-86.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-116.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5986.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	81.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-61.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	79.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	3400.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-92.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	43.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-14.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-70.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-75.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-68.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-55.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-105.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-112.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-435.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-44.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-152.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-19.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-230%)	-18.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-226%)	-44.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-395%)	-152.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1119%)	-91.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-711%)	-252.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1785%)	-48.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-422%)	-51.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-444%)	-40.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-367%)	-67.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-550%)	—	-96.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-744%)	-53.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-455%)	—	139.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+831%)	-76.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-608%)	-71.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-579%)	-78.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-623%)	-53.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-455%)	-30.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-301%)	-26.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	-21.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-246%)	101.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+574%)	—	-119.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-899%)	55.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+270%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1506.00x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-2634.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-313.25x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1155.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-325.25x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-86.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-94.58x Weak Weak Operating income divided by interest expense Optimal: > 5x	-579.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-10.95M	$-11.05M	$-8.23M	$-4.05M	$-5.12M	$-3.28M	$-5.03M	$-4.75M	$-6.35M	$-4.09M	$-1.81M	$-3.49M	$-4.80M	$-1.67M	$-9.00K	$-4.73M	$-5.22M	$-2.54M	$-3.70M	$-5.88M	$-10.46M	$-12.98M	$-109.00K	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—
Basic EPS, GAAP (USD)	$-0.91	$-1.61	$-116.61	$-35.85	$-36.69	$-162.46	$-1.47K	$-319.18	$-2.34K	$-2.85K	$-127.98K	$-22.54K	$-120.95K	$-231.06K	$-147.99K	$-117.16K	$-260.36K	$-507.71K	$-598.84K	$-234.33K	$-442.62K	—	$-429.60K	$-299.42K	$-325.46K	—	—
Free Cash Flow per Share (USD)	$-0.80	$-2.97	—	$-24.71	—	$-92.54	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.70	$6.65	$12.07	$17.08	$37.27	$64.25	—	$347.12	$2.80K	$5.42K	—	—	—	$2.99K	—	—	—	—	—	—	—	—	—	$-6.93K	—	—	—
Tangible Book Value per Share (USD)	$4.70	$6.65	$12.07	$17.08	$37.27	$64.25	—	$347.12	$2.80K	$5.42K	—	—	—	$2.99K	—	—	—	—	—	—	—	—	—	$-6.93K	—	—	—
Basic Weighted Avg Shares (shares)	1.80M	1.24M	—	93,587	78,723	18,758	—	6,635	961	666	—	95	56	10	—	9	7	5	—	5	5	—	—	3	3	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$10.23M	$10.48M	$5.95M	$1.94M	$3.27M	$1.15M	$3.98M	$3.61M	$4.67M	$2.75M	$237.00K	$2.19M	$3.99M	—	$-1.68M	$3.46M	$3.52M	$3.22M	$5.68M	$8.60M	$9.73M	$11.91M	$-1.55M	—	—	—	—
Total Equity (USD)	$10.28M	$10.54M	$6.01M	$1.99M	$3.32M	$1.21M	$4.03M	$3.66M	$4.72M	$2.80M	$259.00K	$2.23M	$4.04M	$31.00K	$-1.62M	$3.46M	$3.67M	$3.36M	$5.82M	$8.73M	$9.85M	$12.03M	$-1.45M	$-24.00K	$969.00K	$-2.09M	$3.21M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	$0.00	$0.00	—	$0.00	$0.00	$0.00	$100.00K	—
Depreciation Expense (USD)	$0.00	$1.00K	$1.00K	$1.00K	$1.00K	$1.00K	$1.00K	—	—	$1.00K	$1.00K	—	—	—	$1.00K	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-2.00M	$-2.00M	$-2.66M	$-3.05M	$-3.05M	$-3.05M	$-1.95M	$-1.89M	$-1.89M	$-1.89M	$-2.00M	$-2.15M	$-2.15M	$-2.40M	$-2.27M	$-2.63M	$-2.63M	$-2.63M	$-3.10M	$-2.64M	$-2.64M	$-2.64M	$-1.47M	$-1.16M	$-1.16M	$-1.16M	—
Operating Cash Flow (USD)	$-1.45M	$-3.69M	$-2.97M	$-2.31M	—	$-1.74M	$-2.00M	—	—	$-2.20M	$-5.56M	—	—	$-2.12M	$-844.00K	—	—	$-2.29M	$-1.58M	—	—	$-2.95M	$-808.00K	$-1.06M	$-1.07M	$-766.00K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters

GRI Bio, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare GRI with peers